Serum levels of free insulin-like growth factor (IGF)-I and IQF-binding protein-1 in prepubertal children with idiopathic short stature
Citation
T. Kamoda et al., Serum levels of free insulin-like growth factor (IGF)-I and IQF-binding protein-1 in prepubertal children with idiopathic short stature, CLIN ENDOCR, 53(6), 2000, pp. 683-688
Categorie Soggetti
Endocrynology, Metabolism & Nutrition","Endocrinology, Nutrition & Metabolism
Journal title
CLINICAL ENDOCRINOLOGY
SICI code
0300-0664(200012)53:6<683:SLOFIG>2.0.ZU;2-W
Abstract
OBJECTIVE The study was performed to evaluate the relationships among serum
free and total insulin-like growth factor (IGF)-I, IGF-binding protein-1 (
IGFBP-1), IGFBP-3, and insulin concentrations in prepubertal children with
idiopathic short stature (ISS).
SUBJECT Eighteen children with ISS and 15 age-matched controls were include
d in the study. All short children had a height standard deviation score of
more than 2 below the mean, and maximum stimulated GH levels greater than
10 mug/l after two standard provocation tests.
RESULTS The serum levels of free IGF-I were significantly lower in short ch
ildren (1.6 +/- 0.3 mug/l) than in the controls (2.8 +/- 0.6 mug/l, P < 0.0
5), while total IGF-I levels were slightly, but not significantly, lower In
short children than in controls. The serum levels of IGFBP-1 were signific
antly higher in the ISS group(124.6 +/- 5.6 <mu>g/l) than in controls (80.0
+/- 8.7 mug/ I, P < 0.0001). The fasting insulin and IGFBP-3 levels were s
imilar in both groups. A stepwise regression analysis for all subjects reve
aled that IGFBP-1 is the only independent predictor of log free IGF-I (R-2
= 0.23, P < 0.01).
CONCLUSIONS The present study shows that the serum levels of free IGF-1 are
significantly lower and insulin-like growth factor-binding protein-1 level
s are higher in prepubertal children with idiopathic short stature, as comp
ared with age-matched controls. The high IGFBP-1 may contribute to growth r
etardation in a subgroup of idiopathic short stature through a decrease in
free IGF-1.